Alexandra Petersson

Medicine & Life Sciences

1. Galectins 100%
2. Peritoneal Neoplasms 96%
3. Pancreatic Neoplasms 94%
4. Molecular Dynamics Simulation 80%
5. Neoplasms 71%
6. Adenocarcinoma 63%
7. Extracellular Matrix 61%
8. Colorectal Neoplasms 57%
9. Drug Therapy 47%
10. Breast Neoplasms 46%
11. Survival 32%
12. Circulating Tumor DNA 26%
13. Lectins 25%
14. Adjuvant Chemotherapy 23%
15. Cytoreduction Surgical Procedures 23%
16. High-Throughput Nucleotide Sequencing 22%
17. Therapeutics 22%
18. Induced Hyperthermia 21%
19. Galactosides 18%
20. Phylogeny 17%
21. Genetic Heterogeneity 17%
22. Gene Amplification 16%
23. Neoplasm Metastasis 16%
24. Focal Adhesion Protein-Tyrosine Kinases 15%
25. MutL Protein Homolog 1 14%
26. AT Rich Sequence 13%
27. Recurrence 13%
28. Lymph Nodes 12%
29. Ampulla of Vater 12%
30. RNA-Binding Motifs 12%
31. Extranodal Extension 12%
32. Single Nucleotide Polymorphism 12%
33. Biomarkers 11%
34. Polysaccharides 11%
35. Microsatellite Instability 11%
36. Proteomics 11%
37. DNA Mismatch Repair 10%
38. Fatal Outcome 10%
39. RNA-Binding Proteins 10%
40. Peritoneum 10%
41. Mutation 10%
42. Genome 9%
43. Staining and Labeling 9%
44. DNA Sequence Analysis 9%
45. Tumor Biomarkers 8%
46. Palliative Care 8%
47. Tumor Burden 8%
48. Cluster Analysis 8%
49. Pharmacology 8%
50. Carrier Proteins 7%